Medicare weighs premium cut after limiting Alzheimer's drug

WASHINGTON (AP) — Medicare said Thursday it's considering a cut in enrollee premiums, after officials stuck with an earlier decision to sharply limit coverage for a pricey new Alzheimer's drug projected to drive up program costs. The agency “is looking at that, and is still going...